Proteomics in cancer research
Authors:
- 1 August 2002
- journal article
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 12 (5) , 409-423
Abstract
With the human genome sequence now determined, the field of molecular medicine is moving beyond genomics to proteomics. In the field of cancer research, the key question is: how can oncologists best use techniques of proteomics in basic research and clinical application? In the postgenomic era, proteomics promises the discovery of biomarkers and tumor markers for early detection and diagnosis, novel protein-based drug targets for anticancer therapy, and new endpoints for the assessment of therapeutic efficacy and toxicity. This review paper will explore key themes in proteomics and their application in clinical cancer research.Keywords
This publication has 63 references indexed in Scilit:
- Clinical ProteomicsJAMA, 2001
- The role of separation science in proteomics researchElectrophoresis, 2001
- Arrays for protein expression profiling: Towards a viable alternative to two-dimensional gel electrophoresis?Proteomics, 2001
- Proteomics on a chip: Promising developmentsElectrophoresis, 2001
- Improved sensitivity proteomics by postharvest alkylation and radioactive labeling of proteinsElectrophoresis, 2000
- Towards high performance two-dimensional gel electrophoresis using ultrazoom gelsElectrophoresis, 2000
- Matrix assisted laser desorption/ionization-time of flight-mass spectrometry analysis of proteins detected by anti-phosphotyrosine antibody on two-dimensional-gels of fibrolast cell lysates after tumor necrosis factor-α stimulationElectrophoresis, 2000
- Proteomics: Capacityversus utilityElectrophoresis, 2000
- The dynamic range of protein expression: A challenge for proteomic researchElectrophoresis, 2000
- The potential use of laser capture microdissection to selectively obtain distinct populations of cells for proteomic analysis — Preliminary findingsElectrophoresis, 1999